drugset / Trial / NCT05589597
EO4010 in Previously Treated Metastatic Colorectal Carcinoma
Non-randomizedSequentialOpen-labelTreatment
Summary
Open-label multicenter study
Timeline
- Start
- 2023-06-01
- Primary completion
- 2025-05-30
- Completion
- 2025-05-30
Outcome
Outcome not reported
Stopped (Enrollment): “Sponsor decision to stop recruitment in context of overall EO4010 development goals. Stop of recruitment was not related to any safety concern, with the safety profile of EO4010 being benign”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EO4010 | Vaccine | — | — |